Neo Ivy Capital Management - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2022$22,000
+144.4%
514
+339.3%
0.02%
+100.0%
Q3 2021$9,000
-75.0%
117
-71.0%
0.01%
-75.0%
Q4 2020$36,000
+500.0%
403
+560.7%
0.04%
+566.7%
Q3 2020$6,000
-33.3%
61
-47.9%
0.01%
+100.0%
Q2 2020$9,000
-71.9%
117
-79.1%
0.00%
-94.2%
Q1 2020$32,000
-94.1%
559
-94.8%
0.05%
-83.0%
Q1 2019$539,000
+37.2%
10,683
+61.0%
0.31%
-1.0%
Q4 2018$393,0006,6350.31%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Zebra Capital Management LLC 20,591$895,0001.43%
Global Alpha Capital Management Ltd. 330,270$14,357,0001.39%
AIMZ Investment Advisors, LLC 73,875$3,211,0001.25%
Hillcrest Asset Management LLC 184,010$7,999,0001.22%
Bridge City Capital, LLC 56,869$2,472,0001.02%
SNYDER CAPITAL MANAGEMENT L P 683,700$29,720,0000.72%
EARNEST PARTNERS LLC 2,188,606$95,139,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 343,347$14,925,0000.53%
PALISADE CAPITAL MANAGEMENT, LP 584,957$25,428,0000.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 45,693$1,986,0000.45%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders